tiprankstipranks
Trending News
More News >
ADM Tronics Unlimited Inc (ADMT)
OTHER OTC:ADMT
US Market
Advertisement

ADM Tronics Un (ADMT) AI Stock Analysis

Compare
17 Followers

Top Page

ADMT

ADM Tronics Un

(OTC:ADMT)

Select Model
Select Model
Select Model
Neutral 50 (OpenAI - 4o)
Rating:50Neutral
Price Target:
$0.00
▼(-100.00% Downside)
The overall stock score of 50 reflects a balance between positive technical momentum and significant financial and valuation challenges. The stock's bullish technical indicators are offset by weak financial performance, high leverage, and a negative P/E ratio, indicating potential risks. Investors should be cautious and consider the company's ability to improve profitability and financial stability.

ADM Tronics Un (ADMT) vs. SPDR S&P 500 ETF (SPY)

ADM Tronics Un Business Overview & Revenue Model

Company DescriptionADM Tronics Unlimited, Inc., through its subsidiaries, develops, manufactures, and sells electronics for non-invasive medical and other applications in the United States, Australia, Asia, and Europe. It operates through Electronics, Chemical, and Engineering segments. The company offers proprietary devices for use in diagnostics and therapeutics of humans and animals; and electronic controllers for spas and hot tubs. It also provides water-based primers and adhesives; water-based coatings and resins; water-based chemical additives; and anti-static conductive paints, coatings, and other products. In addition, the company offers water-based, adhesive and related topical formulations for use in maxillofacial prosthetic medical applications; and for professional makeup applications primarily for film, TV, and theatrical productions. Further, it provides research, development, regulatory, and engineering services for the design, development, and manufacturing of medical devices, electronics, and other technologies and products, as well as medical electronic therapeutic technology. The company was incorporated in 1969 and is headquartered in Northvale, New Jersey.
How the Company Makes MoneyADM Tronics generates revenue through multiple key streams, including the sale of its proprietary medical devices and consumer products, as well as contract manufacturing services for third parties. The company also earns income from research and development collaborations, where it partners with other firms or institutions to create new technologies and bring them to market. Additionally, ADMT benefits from licensing agreements that allow other companies to utilize its technologies, providing a steady stream of royalty income. Strategic partnerships with healthcare providers and manufacturers further enhance its market reach and revenue potential, while ongoing investments in R&D help to diversify its offerings and tap into emerging markets.

ADM Tronics Un Financial Statement Overview

Summary
ADM Tronics Un shows a mixed financial performance with some revenue growth but significant profitability and cash flow challenges. High leverage and negative returns on equity raise concerns about financial stability. The company needs to focus on improving operational efficiency and cash flow generation to enhance its financial health and reduce risks associated with high debt levels.
Income Statement
45
Neutral
The income statement shows a mixed performance. The company has achieved a modest revenue growth rate of 3.83% in the latest year, indicating some positive momentum. However, profitability remains a concern with a negative net profit margin of -3.85% and a negative EBIT margin, reflecting operational challenges. The gross profit margin is relatively healthy at 43.65%, suggesting some efficiency in production or service delivery. Overall, while there is revenue growth, the company struggles with profitability.
Balance Sheet
40
Negative
The balance sheet reveals a high debt-to-equity ratio of 1.26, indicating significant leverage and potential financial risk. The return on equity is negative at -18.33%, reflecting poor returns for shareholders. The equity ratio stands at 31.55%, suggesting a moderate level of equity financing. The company's financial stability is challenged by high leverage and low returns, posing risks to long-term sustainability.
Cash Flow
35
Negative
Cash flow analysis highlights significant challenges. The free cash flow growth rate is negative, indicating a decline in cash generation capabilities. The operating cash flow to net income ratio is very low at 0.87%, suggesting limited cash flow relative to earnings. The free cash flow to net income ratio is 1.0, indicating that free cash flow is equivalent to net income, but overall cash flow performance is weak, impacting liquidity and operational flexibility.
BreakdownTTMDec 2025Dec 2024Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue3.31M3.20M2.85M3.68M3.21M3.09M
Gross Profit1.36M1.40M1.09M1.66M1.25M1.16M
EBITDA68.92K12.29K-514.02K80.35K-1.02M-506.36K
Net Income-67.59K-123.06K-716.85K-96.32K-1.38M-598.28K
Balance Sheet
Total Assets2.39M2.13M2.14M3.09M3.25M5.21M
Cash, Cash Equivalents and Short-Term Investments369.79K382.97K537.04K1.00M1.04M1.55M
Total Debt767.89K846.86K799.66K752.69K918.31K1.58M
Total Liabilities1.39M1.46M1.45M1.52M1.88M2.46M
Stockholders Equity995.10K671.35K692.39K1.57M1.37M2.76M
Cash Flow
Free Cash Flow54.32K9.98K-599.65K125.02K-574.95K-769.64K
Operating Cash Flow54.32K9.98K-585.13K125.02K-574.95K-769.64K
Investing Cash Flow-225.75K-225.75K-14.52K0.000.000.00
Financing Cash Flow71.85K61.70K165.18K-258.56K66.50K877.87K

ADM Tronics Un Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.09
Price Trends
50DMA
0.08
Positive
100DMA
0.07
Positive
200DMA
0.07
Positive
Market Momentum
MACD
<0.01
Positive
RSI
51.86
Neutral
STOCH
73.33
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ADMT, the sentiment is Positive. The current price of 0.09 is below the 20-day moving average (MA) of 0.09, above the 50-day MA of 0.08, and above the 200-day MA of 0.07, indicating a neutral trend. The MACD of <0.01 indicates Positive momentum. The RSI at 51.86 is Neutral, neither overbought nor oversold. The STOCH value of 73.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ADMT.

ADM Tronics Un Risk Analysis

ADM Tronics Un disclosed 17 risk factors in its most recent earnings report. ADM Tronics Un reported the most risks in the "Production" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

ADM Tronics Un Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
50
Neutral
$5.98M-6.71%8.25%85.71%
45
Neutral
$9.24M-193.24%-66.40%65.99%
44
Neutral
$3.16M-440.77%-7.72%99.54%
42
Neutral
$14.85M-195.48%-40.47%96.14%
42
Neutral
$4.37M-1371.21%-13.90%44.89%
40
Underperform
$6.88M-195.55%65.72%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ADMT
ADM Tronics Un
0.09
<0.01
12.50%
NUWE
Nuwellis
3.50
-54.88
-94.00%
SINT
Sintx Technologies
4.14
1.03
33.12%
VERO
Venus Concept
2.35
-2.94
-55.58%
HSCS
Heart Test Laboratories, Inc.
3.49
-0.09
-2.51%
AMIX
Autonomix Medical, Inc.
1.11
-10.71
-90.61%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 01, 2025